𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: Are they really “off the hook”?

✍ Scribed by Brian J. McMahon

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
39 KB
Volume
28
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The absence of hepatitis B virus DNA in
The absence of hepatitis B virus DNA in hepatitis B e antigen positive sera from chronic hepatitis B surface antigen carriers in China
✍ Janet S. Scott; Pei-En Pan; Raymond A. Pace; Theo P. Sloots; Prof. W. Graham Coo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

## Abstract Sera from 20 Chinese patients with chronic hepatitis B were examined for hepatitis B e antigen and hepatitis B virus (HBV) DNA. There was considerable discordance with HBV DNA not being detectable in 10 out of 13 (77%) patients who were hepatitis B e antigen positive. Further testing fo

Precision and stability of hepatitis B v
Precision and stability of hepatitis B virus DNA levels in chronic surface antigen carriers
✍ Annelie Plentz; Gabriele Koller; Klaus M. Weinberger; Wolfgang Jilg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract Quantitative determination of hepatitis B virus (HBV) DNA concentration is the most important measure for an estimation of the infectivity of an HBV positive health care worker and the basis for the decision whether he or she is allowed to perform exposure prone procedures. Thus questio

Quantitative detection of hepatitis B su
Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers
✍ Madoka Kohmoto; Masaru Enomoto; Akihiro Tamori; Daiki Habu; Tadashi Takeda; Nori 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract The usefulness of fully automated chemiluminescent microparticle immunoassay (Architect HBsAg QT) for monitoring serum levels of hepatitis B virus (HBV) during antiviral therapy remains unclear. Using this assay, hepatitis B surface antigen (HBsAg) was measured in 20 patients with chron

Increased risk of hepatocellular carcino
Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1
✍ Zongtang Sun; Peixin Lu; Mitchell H. Gail; David Pee; Qinan Zhang; Lihua Ming; J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

We followed 145 men with chronic hepatitis B virus (HBV) hepatitis for 10 years to determine whether exposure to aflatoxin, or concomitant exposure to hepatitis C virus (HCV), or family history of hepatocellular carcinoma (HCC) increased the risk of developing HCC. We collected 8 monthly urine sampl

Soluble CD14 levels are increased and in
Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients
✍ Sophia Steyaert; Peter Vanlandschoot; Hans Van Vlierberghe; Helmut Diepolder; Ge 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 1 views

## Abstract Because it was observed recently that yeast‐derived recombinant HBsAg interacts in a lipopolysaccharide binding protein‐dependent manner with CD14 expressed on human monocytes, we investigated whether HBsAg influences the serum levels of sCD14, lipopolysaccharide binding protein and C‐r